BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 19673884)

  • 1. UK Myeloma Forum (UKMF) and Nordic Myeloma Study Group (NMSG): guidelines for the investigation of newly detected M-proteins and the management of monoclonal gammopathy of undetermined significance (MGUS).
    Bird J; Behrens J; Westin J; Turesson I; Drayson M; Beetham R; D'Sa S; Soutar R; Waage A; Gulbrandsen N; Gregersen H; Low E;
    Br J Haematol; 2009 Oct; 147(1):22-42. PubMed ID: 19673884
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical practice. Monoclonal gammopathy of undetermined significance.
    Bladé J
    N Engl J Med; 2006 Dec; 355(26):2765-70. PubMed ID: 17192542
    [No Abstract]   [Full Text] [Related]  

  • 3. Monoclonal gammopathies of undetermined significance.
    Kyle RA; Rajkumar SV
    Best Pract Res Clin Haematol; 2005; 18(4):689-707. PubMed ID: 16026745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal gammopathy of undetermined significance: to screen or not to screen for multiple myeloma?
    Go RS
    Br J Haematol; 2010 May; 149(4):620-1; author reply 621-3. PubMed ID: 20148888
    [No Abstract]   [Full Text] [Related]  

  • 5. Involved/uninvolved immunoglobulin ratio identifies monoclonal gammopathy of undetermined significance patients at high risk of progression to multiple myeloma.
    Espiño M; Medina S; Blanchard MJ; Villar LM
    Br J Haematol; 2014 Mar; 164(5):752-5. PubMed ID: 24261626
    [No Abstract]   [Full Text] [Related]  

  • 6. [Benign monoclonal gammopathy].
    Shirota T; Kondo M; Uchida H; Ito H
    Nihon Rinsho; 1995 Mar; 53(3):720-4. PubMed ID: 7699912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    Kyle RA
    Eur J Haematol Suppl; 1989; 51():70-5. PubMed ID: 2516809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The clinical significance of M proteins].
    Sasaki R
    Rinsho Byori; 2001 Jul; 49(7):678-81. PubMed ID: 11519130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Monoclonal gammopathies of undetermined significance called "MGUS"].
    Clément F
    Schweiz Med Wochenschr; 1989 Jul; 119(27-28):970-8. PubMed ID: 2508215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Current status regarding detection of monoclonal component in Japan].
    Yamada T
    Rinsho Byori; 2010 Apr; 58(4):397-400. PubMed ID: 20496769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The diagnostic significance of finding a M-component in serum].
    Schmidt EB; Møller-Petersen J
    Ugeskr Laeger; 1986 Mar; 148(11):633-5. PubMed ID: 3083549
    [No Abstract]   [Full Text] [Related]  

  • 12. Monoclonal gammopathy of undetermined significance and smouldering multiple myeloma: emphasis on risk factors for progression.
    Kyle RA; Rajkumar SV
    Br J Haematol; 2007 Dec; 139(5):730-43. PubMed ID: 18021088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up of patients with monoclonal gammopathy of undetermined significance after kidney transplantation.
    Naina HV; Harris S; Dispenzieri A; Cosio FG; Habermann TM; Stegall MD; Dean PG; Prieto M; Kyle RA; Rajkumar SV; Leung N
    Am J Nephrol; 2012; 35(4):365-71. PubMed ID: 22473253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis and progression of monoclonal gammopathy of undetermined significance.
    Bladé J; Rosiñol L; Cibeira MT; de Larrea CF
    Leukemia; 2008 Sep; 22(9):1651-7. PubMed ID: 18668131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Monoclonal gammopathy of undetermined significance].
    Chaïbi P; Merlin L; Thomas C; Piette F
    Ann Med Interne (Paris); 2002 Nov; 153(7):459-66. PubMed ID: 12598832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal Gammopathy of Undetermined Significance (MGUS)Monoclonal Gammopathy of Undetermined Significance (MGUS).
    Viera S; Ludek P; Zdeněk A; Marta K; Martin Š; Sabina Š; Zdeněk K
    Klin Onkol; 2018; 31(4):270-276. PubMed ID: 30541309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    Kyle RA; Rajkumar SV
    Hematol Oncol Clin North Am; 2007 Dec; 21(6):1093-113, ix. PubMed ID: 17996590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal gammopathy of undetermined significance: a consensus statement.
    Berenson JR; Anderson KC; Audell RA; Boccia RV; Coleman M; Dimopoulos MA; Drake MT; Fonseca R; Harousseau JL; Joshua D; Lonial S; Niesvizky R; Palumbo A; Roodman GD; San-Miguel JF; Singhal S; Weber DM; Zangari M; Wirtschafter E; Yellin O; Kyle RA
    Br J Haematol; 2010 Jul; 150(1):28-38. PubMed ID: 20507313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Monoclonal gammopathy and osteolytic lesions as the initial manifestation of a metastatic hypernephroma].
    Castillo Jimeno JM; Illarramendi Mañas JJ; Ruiz Rubio JL; Santiago González A; Sebastián Borruel JL
    Arch Esp Urol; 1991 Nov; 44(9):1110-2. PubMed ID: 1807217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Monoclonal gammopathy of undetermined significance--potential risk factor of multiple myeloma].
    Stelmach-Gołdyś A; Czarkowska-Paczek B
    Przegl Lek; 2012; 69(5):194-6. PubMed ID: 23050415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.